Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
Appl Immunohistochem Mol Morphol ; 11(1): 1-8, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12610349

ABSTRACT

Metaplastic carcinomas of the breast (MCBs) are unusual neoplasms characterized by an admixture of glandular epithelial components, which frequently exhibit features of squamous differentiation, and mesenchymal malignant components. Regardless of the presence of myoepithelial features in MCB, no consensus concerning their putative histogenesis has yet been achieved. Recently, novel putative myoepithelial markers have been developed, including p63, maspin, and P-cadherin. We assessed the expression of these myoepithelial markers in MCBs and compared their expression with classic myoepithelial markers. Immunohistochemistry using the streptavidin-biotin-peroxidase complex technique with antibodies raised against p63, maspin, P-cadherin, actin (clones CGA7, 1A4 and HHF35), cytokeratin 14 (Ck14), and vimentin was performed on 16 MCBs (7 matrix-producing MCBs, 6 adenosquamous MCBs, and 3 MCBs with heterologous elements). In healthy breast lobules and ducts adjacent to the tumors, myoepithelial cells showed distinctive and consistent immunoreactivity for p63, maspin, P-cadherin, actin, S-100 protein, and Ck14. Matrix-producing MCBs were positive for maspin in all cases, for p63 in 4 of 7 cases, and for P-cadherin in 4 of 7 cases. Adenosquamous MCB showed immunoreactivity for p63, maspin, and P-cadherin in 5 of 6 cases. All novel myoepithelial markers and Ck14 decorated squamous cell islands. MCBs with heterologous elements were positive for p63 in 1 case, for maspin in all 3 cases, and for P-cadherin in 2 cases. All cases showed at least one of the novel myoepithelial markers. Eleven of 16 cases were positive for actin. Eleven of 14 cases reacted with Ck14, and all cases that stained for S-100 protein (9 of 9) and vimentin (13 of 13) were also positive. Based on our findings, the balance of probabilities favors that MCBs may have a basal or myoepithelial cell histogenesis and differentiation.


Subject(s)
Breast Neoplasms/metabolism , Membrane Proteins , Stem Cells/metabolism , Actins/metabolism , Adult , Aged , Biomarkers , Breast Neoplasms/pathology , Cadherins/metabolism , DNA-Binding Proteins , Female , Genes, Tumor Suppressor , Humans , Immunohistochemistry , Keratins/metabolism , Middle Aged , Phosphoproteins/metabolism , S100 Proteins/metabolism , Trans-Activators/metabolism , Transcription Factors , Tumor Suppressor Proteins , Vimentin/metabolism
2.
Arch Pathol Lab Med ; 126(6): 723-6, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12033965

ABSTRACT

The sarcomatoid variant of anaplastic large cell lymphoma is one of the rarest histologic variants of this neoplasm. Due to its sarcomatoid features, it is frequently misdiagnosed as a poorly differentiated sarcoma, anaplastic carcinoma, or melanoma. We report the case of a 92-year-old woman with a sarcomatoid anaplastic large cell lymphoma mimicking a primary breast neoplasm. The patient presented with a rapidly enlarging lump in the left breast and nodules in the right axilla. The immunohistochemical profile showed reactivity for leukocyte common antigen, UCHL-1, vimentin, and CD30, but immunoexpression of anaplastic lymphoma kinase was lacking. Anaplastic large cell lymphomas are lymphoid neoplasms of T-cell/null-cell lineage that consistently express the activation marker CD30 and usually carry a gene rearrangement of the anaplastic lymphoma kinase gene. To the best of our knowledge, this is the first reported case of sarcomatoid anaplastic large cell lymphoma presenting as a primary breast neoplasm in which anaplastic lymphoma kinase expression was assessed.


Subject(s)
Breast Neoplasms/pathology , Lymphoma, Large-Cell, Anaplastic/pathology , Sarcoma/pathology , Aged , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/analysis , Cyclophosphamide/administration & dosage , Diagnosis, Differential , Doxorubicin/administration & dosage , Fatal Outcome , Female , Humans , Ki-1 Antigen/analysis , Leukocyte Common Antigens/analysis , Lymphoma, Large-Cell, Anaplastic/chemistry , Lymphoma, Large-Cell, Anaplastic/drug therapy , Male , Methotrexate/administration & dosage , Prednisolone/administration & dosage , Sarcoma/chemistry , Sarcoma/drug therapy , Vimentin/analysis , Vincristine/administration & dosage
3.
Head Neck ; 24(3): 307-11, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11891965

ABSTRACT

BACKGROUND: Eosinophilic angiocentric fibrosis (EAF) is a rare fibroinflammatory lesion of the sinonasal tract that occurs mainly in young to middle-aged female patients. Only two previous cases affecting male patients have been reported, and its etiopathogenesis remains unknown. The authors report on the third case of the entity in a male patient and review the 12 previously reported cases. CASE REPORT: A 52-year-old male patient was initially seen with a 15 years history of allergic rhinitis, progressive nasal obstruction, and left-sided hearing loss. All laboratory tests were unremarkable, except the nasal discharge eosinophil count that showed a conspicuous eosinophilia. The video-assisted-nasofibroscopic examination and CT scans disclosed a thickened deviated nasal septum with a subjacent infiltrative lesion. The histologic analysis of the nasal septum showed a variable mixed inflammatory cellular infiltration mainly composed of eosinophils, plasma cells, and histiocytes with a perivascular distribution; in other areas, an angiocentric fibrosing lesion with a peculiar perivascular onion-skin pattern was observed. The patient had a partial resection of the lesion with symptomatic control. CONCLUSIONS: The presence of rhinitis and nasal eosinophilia in our case associated with the clinical aspects of the previously reported cases further support an allergic cause for EAF.


Subject(s)
Eosinophils/pathology , Nasal Cavity/pathology , Nose Diseases/pathology , Fibrosis , Humans , Male , Middle Aged , Nasal Bone/pathology , Nasal Mucosa/pathology , Nasal Septum/pathology , Nose Diseases/diagnosis , Paranasal Sinus Diseases/pathology
4.
J Cutan Pathol ; 29(1): 48-51, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11841518

ABSTRACT

BACKGROUND: Giant cell collagenoma (GCC) is a recently described cutaneous fibrous neoplasm that usually affects young to middle-aged adults. Despite its similar histological appearance with circumscribed storiform collagenoma, no association of GCC with Cowden's syndrome has been described so far. To the best of our knowledge only five cases of this rare fibrous tumor have been reported so far. METHODS: We report a case of a 79-year-old male patient presenting with a slow growing flesh-colored dome-shaped lesion in his left forearm, with a clinical diagnosis of fibroma. No stigma of Cowden's syndrome was depicted. RESULTS: The histological analysis showed a symmetrical and well-circumscribed flat-dome-shaped lesion covered by an atrophic overlying epidermis. The neoplasm was composed of hyalinized collagen bundles disposed in a whorled storiform pattern. Admixed with the collagen matrix, there were two distinct cell populations, one composed by spindle-shaped mononuclear cells, and the other composed by bizarre multinucleated giant cells. Immunohistochemical analysis showed positivity for vimentin and actin HHF35 in the mononucleated. The multinucleated cells only immunoexpressed vimentin. CONCLUSION: GCC is an unusual cutaneous fibrous tumor that should be differentiated from circumscribed storiform collagenoma, pleomorphic fibroma, regressive forms of dermatofibroma, and solitary myofibroma based on its histological features.


Subject(s)
Fibroma/pathology , Skin Neoplasms/pathology , Actins/analysis , Aged , Collagen/analysis , Fibroma/chemistry , Fibroma/surgery , Giant Cells/chemistry , Giant Cells/pathology , Humans , Immunoenzyme Techniques , Leukocytes, Mononuclear/chemistry , Leukocytes, Mononuclear/pathology , Male , Sclerosis/pathology , Skin Neoplasms/chemistry , Skin Neoplasms/surgery , Vimentin/analysis
5.
Rev. bras. cancerol ; 36(1/4): 13-6, jan.-dez. 1990. ilus, tab
Article in Portuguese | LILACS | ID: lil-157790

ABSTRACT

A técnica de imunoperoxidase foi usada para testar a especificidade do CEA (antígeno carcinoembriônico) e EMA (antígeno de membrana epitelial) em células epiteliais esfoliadas de líquidos cavitários neoplásicos ou reativos. O CEA mostrou-se específico para células tumorais, derivadas de carcinoma. O EMA revelou positividade näo só em células tumorais, mas em 61,5 porcento dos líquidos näo neoplásicos. A coloraçäo para CEA mostrou-se útil näo só no diagnóstico diferencial de células do carcinoma, como também para visualizaçäo de raras células tumorais isoladas em meio a células mesoteliais e inflamatórias.


Subject(s)
Humans , Carcinoembryonic Antigen , Pericardial Effusion/cytology , Ascitic Fluid/cytology , Neoplasms , Pleural Effusion/cytology , Immunoenzyme Techniques
SELECTION OF CITATIONS
SEARCH DETAIL
...